99-13348. Ear, Nose, and Throat Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 64, Number 101 (Wednesday, May 26, 1999)]
    [Notices]
    [Page 28501]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-13348]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Ear, Nose, and Throat Devices Panel of the Medical Devices 
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
         This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). At least one 
    portion of the meeting will be closed to the public.
        Name of Committee: Ear, Nose, and Throat Devices Panel of the 
    Medical Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on June 18, 1999, 8:30 a.m. 
    to 5:30 p.m.
        Location: Corporate Bldg., conference room 020B, 9200 Corporate 
    Blvd., Rockville, MD.
        Contact Person: Harry R. Sauberman, Center for Devices and 
    Radiological Health (HFZ-460), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-594-2080, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12522. Please call the Information Line for 
    up-to-date information on this meeting.
        Agenda: The committee will discuss generic issues relating to the 
    safety and efficacy of middle ear amplification devices.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by June 4, 1999. 
    Oral presentations from the public will be scheduled between 
    approximately 9 a.m. and 10 a.m., and for an additional 30 minutes near 
    the end of the committee deliberations. Time allotted for each 
    presentation may be limited. Those desiring to make formal oral 
    presentations should notify the contact person before June 4, 1999, and 
    submit a brief statement of the general nature of the evidence or 
    arguments they wish to present, the names and addresses of proposed 
    participants, and an indication of the approximate time requested to 
    make their presentation.
        Closed Committee Deliberations: On June 18, 1999, from 4:30 p.m. to 
    5:30 p.m., the meeting will be closed to the public to permit 
    discussion and review of trade secret and/or confidential commercial 
    information (5 U.S.C. 552b(c)(4)) relating to present and future agency 
    issues.
         Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: May 20, 1999.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 99-13348 Filed 5-25-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
05/26/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-13348
Pages:
28501-28501 (1 pages)
PDF File:
99-13348.pdf